Home › Targets › BTK
BTK (1 companies · 10 programs)
Companies with an active program directed at BTK.
- bexobrutideg — Chronic Lymphocytic Leukemia Phase 2
- bexobrutideg — Small Lymphocytic Lymphoma Phase 2
- bexobrutideg — Waldenström's Macroglobulinemia Phase 1
- bexobrutideg — Follicular Lymphoma Phase 1
- bexobrutideg — Marginal Zone Lymphoma Phase 1
- zelebrudomide — Diffuse Large B-Cell Lymphoma Phase 1
- zelebrudomide — Mantle Cell Lymphoma Phase 1
- zelebrudomide — Chronic Lymphocytic Leukemia Phase 1
- zelebrudomide — Marginal Zone Lymphoma Phase 1
- zelebrudomide — Waldenström's Macroglobulinemia Phase 1
